background: Whether extended culture allowing selection of embryos with high development potential has any advantage over cleavage-stage embryo transfer remains a matter of debate. Among the currently unsolved questions, the cumulative delivery rate resulting from fresh and frozen embryo transfers needs to be taken into account in both strategies. The aim of our study was, therefore, to compare the efficacy of single embryo transfer either on Day 2 or on Day 5/6 combining fresh and frozen embryo transfers.
Introduction
Multiple pregnancies are a common and serious complication of IVF procedures. In Europe in 2004, 21.7% of all IVF pregnancies were twin pregnancies (Nyboe-Andersen et al., 2008) compared with the 1.6% twin pregnancies after natural conception (ESHRE Capri Workshop Group, 2000) . Moreover, adverse outcomes associated with high-order gestations include the increased incidence of maternal, perinatal and neonatal morbidity and mortality (Land and Evers, 2003) .
Single embryo transfer is the most successful way to reduce the frequency of multiple pregnancies in IVF (Bergh, 2005) . However, the main challenge is to avoid twin pregnancies without decreasing the chance of having a baby. Previous studies including .100 cycles showed that similar pregnancy and delivery rates were achieved in selected patients with elective single embryo transfer (eSET) compared with double embryo transfer either on Day 2 or on Day 3 (De Sutter et al., 2003; Tiitinen et al., 2003; Thurin et al., 2004; Van Montfoort et al., 2004) . The implantation rates in these studies ranged from 28.2% (De Sutter et al., 2003) to 39.7% (Van Montfoort et al., 2004) after the transfer of a single top-quality embryo on Day 2/3.
It has been suggested that extending embryo culture to Day 5/6 in order to transfer the embryo at the blastocyst stage would enhance the likelihood of pregnancy (Marek et al., 1999; Gardner et al., 2000 Gardner et al., , 2004 . Some studies including .100 selected patients have reported high pregnancy rates after single blastocyst transfer (SBT) on Day 5 (Henman et al., 2005; Nilsson et al., 2005; Papanikolaou et al., 2006) . In such conditions, the implantation rate ranged from 33.1% (Papanikolaou et al., 2006) to 45.0% (Henman et al., 2005) .
What is the best way to identify an embryo with the highest potential for subsequent implantation? Are early morphological parameters on Day 1 or Day 2/3 reliable enough to determine embryo viability, or is it better to culture embryos to reach the blastocyst stage? To our knowledge, only two studies have compared eSET and SBT (Papanikolaou et al., 2006; Zech et al., 2007) . These prospective randomized studies showed that in selected groups of patients, SBT resulted in significantly higher pregnancy rates (Zech et al., 2007) and delivery rates (Papanikolaou et al., 2006) compared with eSET on Day 3. However, none of these studies reported the outcome of frozen embryo transfers. Embryo cryopreservation following IVF cycles provides further possibilities of success, in addition to those achieved with fresh embryo transfer . Cumulative birth rates after completion of fresh and additional frozen embryo transfers have therefore to be considered when single embryo transfer (at cleavage or blastocyst stage) is proposed.
The aim of our study was therefore to compare the efficacy of single embryo transfer, either on Day 2 or on Day 5/6, in terms of delivery rates, combining both fresh and frozen embryo transfers.
Materials and Methods
This prospective study was initiated at the IVF Unit, Bretonneau University Hospital, Tours, France, between January 2003 and December 2006. A total of 1539 couples were offered eSET/SBT transfer in the course of a first or second attempt at classical IVF or ICSI. Patients were clearly informed about the risks of multiple pregnancies. In the study period, 478 couples were scheduled on a voluntary basis for single embryo/blastocyst transfer. Among the global population including 1539 couples, the volunteers (n ¼ 478) were significantly younger compared with the nonvolunteers (n ¼ 1061) [female age: 31.9 + 4.1 (volunteers) versus 32.9 + 4.3 years (non-volunteers), P , 0.0001 and male age: 34.7 + 5.8 (volunteers) versus 35.3 + 5.7 years (non-volunteers), P , 0.03]. However, regarding biological and clinical characteristics (rate of normal fallopian tubes, normal ovulation rate, endometriosis rate, sperm concentration, sperm motility, normal spermatozoa and duration of infertility), volunteers did not differ from non-volunteers. At the initial IVF screening and follow-up appointments, theoretical advantages and drawbacks of both strategies were explained to volunteer couples (embryos selection after genomic activation during extended culture, more accurate synchrony between blastocyst and endometrium, lower uterine contractility at the time of blastocyst transfer, uncertainty of extended culture to reach the blastocyst stage, lower survival and implantation rates with frozen blastocyst transfers compared with frozen embryo transfers). The physician and the volunteer couple decided together to schedule the transfer of either 1 cleavage-stage embryo on Day 2 (eSET group, n ¼ 243) or 1 Day 5/6 blastocyst (SBT group, n ¼ 235), regardless of the number or quality of the embryos on Day 2. Couples were therefore allocated in a non-randomized manner to each group. Each of the 478 couples was included once in the study.
The primary outcome measurement was the cumulative delivery rate, including fresh and frozen embryo transfers in both groups. Secondary outcomes concerned the implantation rates after fresh or frozen embryo/ blastocyst transfers, embryo survival and multiple delivery rate after freezing.
The ovarian stimulation protocol and the IVF and ICSI procedures used have already been described elsewhere (Guerif et al., 2004) , and embryo culture with sequential media (until Day 2 or Day 5/6) and assessments were carried out as described previously (Guerif et al., 2007) . Briefly, fertilization (Day 0) was performed in G-Fert TM (Vitrolife, Gothenburg, Sweden). The following morning (Day 1), the oocytes were individually placed in microdrops (25 ml) in G1-2 TM (Vitrolife) under mineral oil.
From Day 3 to Day 5/6, embryo culture was performed in microdrops (25 ml) in G2-2 TM (Vitrolife) under mineral oil. All cultures were performed in incubators at 378C with 6% CO 2 , 5% O 2 and 89% N 2 .
All subsequent optical assessments were performed using an inverted microscope with Hoffman modulation contrast (Â200 and Â400 magnifications). Oocytes were checked for fertilization 18 -20 h after insemination/ICSI (Day 1). On Day 2, individually cultured embryos were evaluated 44 -46 h post-insemination/ICSI on the basis of the number of blastomeres, blastomere size, fragmentation rate and presence of multinucleated blastomeres. Embryo morphology on Day 2 was converted to an embryo score. The number of points given to each parameter studied was weighted according to previous findings (Guerif et al., 2007) . Briefly, 4-cell embryos were given 2 points, 5-or 6-cell embryos 1 point and 2-or 3-cell embryos on Day 2 zero. Embryos with regular and even numbers of blastomeres were given 2 points, as well as embryos with irregular and uneven numbers of blastomeres. Only 1 point was given to other embryos. Embryos with ,20% fragmentation were assigned 2 points, 1 point to embryos with 20 -50% fragmentation and 0 when the fragmentation rate was .50%. The final embryo score was then calculated by adding up points for the different features. Embryos with four regular blastomeres, ,20% fragmentation and no multinucleated blastomeres were classified as top-quality embryos with a score of 6 points. Embryos with one or more multinucleated blastomeres were excluded from transfer and cryopreservation on Day 2 and from further extended embryo culture.
Extended culture concerned the whole embryo cohort for SBT group, whereas it concerned only the remaining embryos after transfer or freezing on Day 2 for eSET group. The blastocyst assessment was based on the expansion of the blastocoelic cavity and the number and cohesiveness of the inner cell mass and trophectoderm cells (Gardner and Schoolcraft, 1999) . A blastocyst with good morphology was defined as having a well expanded blastocoele cavity (B3 -B6) on Day 5, a well-defined inner cell mass (A or B) and a single layer of trophectoderm cells surrounding the cavity (A or B) (Gardner et al., 2000) .
In the eSET group, only supernumerary top-quality embryos were frozen on Day 2. All other non-top-quality embryos were thus placed for further extended culture until the blastocyst stage. At this stage, only good morphology blastocysts were frozen on Day 5/6. In the SBT group, the whole cohort was placed in extended culture for transfer and possible cryopreservation on Day 5/6 only for good morphology blastocysts. Procedures of freezing-thawing of cleavage-stage embryos (Guerif et al., 2002) and blastocysts (Guerif et al., 2003) have been described previously. Depending on the couple, one or two cleavage-stage embryo(s)/ blastocyst(s) were transferred after thawing in cryopreserved cycles.
Serum hCG levels were measured 10 days after cleavage-stage embryo transfer and 7 days after blastocyst transfer. Clinical pregnancy was defined as the presence of a gestational sac with fetal heart activity on ultrasound examination 7 weeks after oocyte retrieval. The implantation rate was defined as the number of gestational sacs divided by the number of embryos transferred.
Statistical analysis
Statistical analysis was performed using Statview 4.1 software (Abacus Concepts, Berkeley, CA, USA). Quantitative variables were compared using variance analysis followed by Fisher's PLSD test, whereas qualitative data were compared using contingency tables (x 2 test). Differences were considered significant if P , 0.05.
Results
A total of 478 couples were assigned to undergo single embryo transfer of either a cleavage-stage embryo (eSET, n ¼ 243 patients) or a blastocyst (SBT, n ¼ 235 patients). There was no difference between the two groups for female and male biological/clinical characteristics ( Table I) . The proportions of patients undergoing IVF cycles for their first conception attempt were similar in both groups (75% versus 72% in the eSET and SBT groups, respectively). The percentage of couples in their first oocyte retrieval rank was 86% (208/243) in the eSET group, whereas it was only 71% (166/235) in the SBT group (P , 0.0001). There was no difference in the total number of mature (metaphase II) oocytes retrieved, fertilization rate or number of embryos obtained in the eSET or SBT groups (Table II) . The number of top-quality embryos and embryo score on Day 2 showed that the embryo quality of the whole cohort was similar in both groups. The percentage of patients with at least one top-quality embryo on Day 2 was similar in the two groups (68% in the eSET group and 65% in the SBT group).
All the Day 2 embryos in the SBT group were exposed to extended culture. As a consequence, the number of embryos cultured in vitro until Day 5/6, the total number of blastocysts and the number of cryopreserved blastocysts were significantly higher in the SBT group compared with the eSET group (Table II) . Although the rate of blastocyst development differed slightly between the groups (42% versus 58% for eSET and SBT groups, respectively), the percentage of cycles with blastocyst cryopreservation was markedly higher in the SBT group compared with the eSET group (55% versus 18%, respectively; P , 0.0001). Conversely, the overall mean number of embryos cryopreserved, including Day 2 embryos and blastocysts, was higher in the eSET group (1.7 + 1.9) than in the SBT group (1.2 + 1.4, P , 0.003).
The clinical outcome of the two groups in terms of fresh cycles is shown in Table III . In the SBT group, 17 of 235 patients (7%) did not undergo transfer due to the absence of a blastocyst on Day 5/6 (16 patients) or occurrence of ovarian hyperstimulation syndrome (1 patient). Both clinical implantation rate (43.6% versus 29.6%, respectively; P , 0.004) and delivery rate per oocyte retrieval (34.0% versus 25.1%, respectively; P , 0.05) were significantly higher in the SBT group compared with the eSET group. Miscarriage and ectopic pregnancy rates were similar in both groups. The overall frequency of multiple deliveries was 2.8% and was similar in both groups (1.6% in the eSET group versus 3.8% in the SBT group). All multiple deliveries were monozygotic twins (one in the eSET group and three in the SBT group). For unsuccessful fresh transfers, the percentage of couples then allocated to a thawing cycle was 95% in the eSET group and 88% in the SBT group. In fact, five couples in the eSET group and nine couples in the SBT group were lost to follow-up. In the eSET group, 216 of 252 frozen Day 2 embryos (86%) and 59 of 71 frozen blastocysts (83%) were thawed and 154 embryos and 34 blastocysts were transferred. In the SBT group, 138 of 178 frozen blastocysts were thawed (78%), and 82 were transferred (Table IV) . Combining both groups, the survival rate after thawing was higher for cryopreserved Day 2 embryos compared with cryopreserved Day 5/6 blastocysts (77% versus 65%, respectively; P , 0.03). In the eSET group, the rate of transfer of a single frozen-thawed embryo/blastocyst was 52%, whereas the rate of transfer of a single frozen-thawed blastocyst was 66% in the SBT group. The clinical implantation rate tended to be higher in the eSET group compared with the SBT group, whatever the number of embryos/blastocysts transferred. Delivery rate per transfer cycle was slightly higher for the eSET group, without reaching statistical significance. The multiple delivery rate was 17.6% in the eSET group (one twin and two triplets), whereas no multiple delivery occurred in the SBT group. All these multiple deliveries were related to the transfer of one (one twin delivery) or two (two cases of triplet deliveries) Day 2 frozen embryos.
The cumulative number of pregnancies and deliveries including fresh and frozen embryo transfers is summarized in Table V. In the eSET group, 26 additional deliveries were achieved following frozen embryo transfers, whereas only 9 were achieved in the SBT group. The cumulative delivery rate per cycle was similar in both groups (34.2% in the eSET group and 37.9% in the SBT group). Regarding cumulative multiple delivery rate, no difference was observed between both groups. Conversely, the ratio between cycle (fresh and frozen) and delivery numbers was higher in the eSET than the SBT group (4.65 versus 3.49 cycles/delivery, respectively; P , 0.04).
Discussion
The aim of an IVF procedure should be to allow couples to take home a single healthy baby per stimulated cycle. However, the question remains regarding which stage is optimal for the transfer of a single embryo into the uterus. To try to resolve this question, 478 couples were assigned to single embryo transfer at either the cleavage stage (eSET group) or the blastocyst stage (SBT group) for their first or second IVF attempt (but only once in this study). Following fresh transfers, both implantation and delivery rates were significantly higher in the SBT group compared with the eSET group. However, when additional deliveries resulting from frozen embryo transfers in the eSET group (cleavage or blastocyst stage) and in the SBT group (blastocyst stage only) were taken into account, the cumulative delivery rate including fresh and frozen embryo transfers was similar in both groups.
In our study, couples assigned to either eSET or SBT had similar clinical and biological characteristics, supporting the absence of any selection bias in the two groups. The characteristics of the cycles were similar in both groups, except for a significantly higher rank of oocyte retrieval in the SBT group, possibly explained by the fact that SBT was more often chosen at the second cycle. On the other hand, the numbers of total embryos or top-quality embryos and embryo scores were similar in both groups, thus precluding selection bias at this stage of the procedure. These findings contrasted with those of previous reports on the efficacy of SBT, where couples were selected before oocyte retrieval [i.e. Day 3 FSH , 10 mIU/ml and at least 10 follicles .12 mm in diameter on the day of hCG administration (Gardner et al., 2004) ], or after oocyte retrieval [i.e. at least three 8-cell stage embryos on Day 3 (Criniti et al., 2005) ] or at least three blastocysts were suitable either for transfer or for cryostorage (Henman et al., 2005) . As human embryo gene expression is switched on at around the 8-cell stage before compaction (Braude et al., 1988) , only embryos that undergo the transition from maternal to embryonic genome might reach the blastocyst stage. Furthermore, there are both cytoplasmic and nuclear reasons why a large proportion of embryos stop developing before implantation. Many reports have underlined the difficulties of correctly selecting the best embryo on Day 2 (Guerif et al., 2007) or on Day 3 (Rijnders and Jansen, 1998; Milki et al., 2002) . The aim of extending embryo culture to Day 5/6 is to select an embryo with increased probability of implantation rather than to improve embryo quality. However, this aim might be counterbalanced by the absence of a blastocyst at the end of extended culture. In fact, blastocyst transfer was available for 93% couples in our study, whereas the overall blastocyst development rate was 58% of embryos cultured. These results are consistent with previous findings in the literature, reporting at least 95% blastocyst transfer in selected and unselected patients (Criniti et al., 2005; Nilsson et al., 2005) , whereas 40 -60% fertilized oocytes were able to reach the blastocyst stage (Gardner et al., 1998; Behr et al., 1999) . In our study, a significantly higher implantation rate was observed in the SBT group compared with the eSET group (43.6% versus 29.6%, respectively). Couples assigned to SBT were thus more likely to achieve delivery compared with couples who underwent single cleavage-stage embryo transfer. Our results are in accordance with two previous studies comparing SBT and eSET that reported significantly higher delivery rates (32.0% versus 21.6%, respectively) (Papanikolaou et al., 2006) and higher pregnancy rates (32.8% versus 23.2%, respectively) (Zech et al., 2007) with SBT. How can the higher implantation rate after SBT compared with single cleavage-stage embryo transfer be explained? First, higher implantation rates have been reported in many mammalian species using transfer at the morula or blastocyst stage than at the cleavage stage (Bavister, 1995) . Second, a better embryo selection process might be made possible at the blastocyst stage. The aneuploidy rate has been reported to be lower for blastocysts compared with top-quality Day 3 embryos, even when genetic abnormalities have not prevented development to the blastocyst stage (Magli et al., 2000; Staessen et al., 2004) . Third, as the oviduct and uterus provide different nutritional environments for the developing embryo, the transfer to an inappropriate part of the reproductive tract in relation to developmental stage might involve metabolic stress that might impair embryo viability (Gardner et al., 1998) . Moreover, embryos are transferred after IVF treatment following uterus exposure to supraphysiological concentrations of hormones. In terms of the uterine environment, uterine receptivity has been reported to be impaired in oocyte donors when compared with that of recipients with ovarian failure in a shared oocyte program (Check et al., 1995) . Results from animal models have shown that embryo development is significantly impaired by an oviductal environment exposed to superovulation (Van der Auwera et al., 1999) . Blastocyst transfer should make it possible to minimize or delay embryo exposure to such an environment. Moreover, high frequency of uterine contractions has been reported to be associated with low pregnancy rates (Fanchin et al., 1998) , whereas the frequency decreases significantly over time following hCG administration (Fanchin et al., 2001) . Therefore, transferring human embryos at the blastocyst stage might decrease the risk of embryo expulsion from the uterus.
Following the first reports on eSET, reducing the twin pregnancy rate has been considered a major goal since 2000 (ESHRE Capri Workshop Group, 2000) . While preventing dizygotic twinning, neither eSET nor SBT precludes monozygotic twinning. The overall monozygotic twinning rate of 2.8% in our study confirmed the ability of single embryo transfer to reduce markedly the multiple pregnancy rate compared with transfer of higher numbers of embryos (Nyboe-Andersen et al., 2008) . Regarding fresh transfers, the monozygotic twinning rate was slightly higher in the SBT group compared with the eSET group (3.8% versus 1.6%, respectively; NS), whereas both rates appear higher than the expected in natural conception [1 in 330 spontaneous live births (Hall, 2003) ranging from 2% (Henman et al., 2005) to 5.6% (Milki et al., 2003) following SBT. However, to the best of our knowledge, no study has had enough power to assess the risk of monozygotic twinning. Further studies are still required to address this issue. Although the mechanisms of monozygotic twinning in such conditions remain unclear, patients should be counseled about this since monozygotic twinning is associated with higher perinatal morbidity and mortality, compared with dizygotic twinning (Lopriore et al., 2008) . In our study, patients failing to achieve a pregnancy after fresh embryo transfer performed frozen embryo/blastocyst transfer of one embryo/blastocyst in only 52% of cases for the eSET group and one blastocyst in 66% of cases for the SBT group. In all other situations, two embryos or blastocysts were transferred (48% and 34% for eSET and SBT groups, respectively). Although eSET or SBT clearly aimed to reduce the risk of multiple pregnancy, transfers of cryopreserved embryos following a first or second failure were exposed to a lesser efficiency that might preclude the decision of the couple to go on with the same strategy. In our study, the implantation rate was slightly higher in the eSET group (16.9% for thawed embryos and 14.7% for thawed blastocysts) compared with the SBT group (11.0%), without reaching statistical significance. Furthermore, there were almost twice as many frozen embryo transfers (embryo or blastocyst) in the eSET group as in the SBT group, thus leading to more than twice as many deliveries in the eSET group compared with the SBT group. Combining results from all thawing cycles, the live birth rate was 15.2% after transfer of frozen-thawed cleavagestage embryos and 13.1% for frozen-thawed blastocysts in our study. These findings are in accordance with previous studies reporting a delivery rate of 15% per thawing cycle for frozen-thawed cleavage-stage embryos (Papanikolaou et al., 2006) and of 11% per thawing cycle for frozen-thawed blastocysts ( Van den Abbeel et al., 2005) . From a practical point of view, despite better selection of the embryos frozen in a Day 5/6 freezing program, the outcome after thawing and transfer was not substantially enhanced. Two common techniques are currently available for human embryo cryopreservation, the older slow-cooling method and the more recent rapid procedure known as vitrification. Vitrification has become an attractive alternative to slow freezing, since it appears to result in significantly higher survival and pregnancy rates (Youssry et al., 2008) .
Despite encouraging reports in good-prognosis patients, single embryo transfer is not widely practiced worldwide. Many patients still want to have multiple embryos transferred to increase the probability of pregnancy, although freezing spare embryos may help couples to accept single embryo transfer (Blennborn et al., 2005) . Information regarding cumulative pregnancy rates, combining fresh and frozen embryo transfers, might therefore help both physicians and patients in their decision. One large multicenter study reported high cumulative pregnancy rates (47%) following eSET in selected patients (Martikainen et al., 2001) . On the other hand, one smaller scale study reported high cumulative pregnancy rates (76%) following SBT in selected patients (Henman et al., 2005) . It should be noted that these studies involved frozen embryo transfer of one or two embryos (or blastocysts). In our study, the cumulative delivery rates including fresh and frozen embryo transfers were similar in the eSET and SBT groups (34.2% versus 37.9%). Thus, the benefit of SBT following fresh embryo transfer was not confirmed after frozen embryo transfer in our study.
Indeed, although blastocysts can be successfully cryopreserved, their implantation potential after freezing varies considerably between centers but is always lower than after fresh blastocyst transfer (Gardner et al., 2000; Langley et al., 2001; Pantos et al., 2001; Behr et al., 2002; Guerif et al., 2003; Veeck et al., 2004; Van den Abbeel et al., 2005) .
To our knowledge, no prospective study has compared eSET and SBT integrating cumulative delivery rates per oocyte retrieval in both fresh and frozen embryo transfers. Our overall results show that, in women undergoing their first or second IVF attempt, the chance of taking home a baby was significantly increased after the transfer of a single blastocyst when compared with the transfer of a single cleavagestage embryo. However, in cases of unsuccessful initial transfer, more deliveries originated from frozen-thawed embryo transfers than from frozen -thawed blastocyst transfers, resulting in similar cumulative delivery rates. Failed fresh eSET treatments followed by transfers of frozen -thawed embryos were associated with an increased rate in multiple deliveries, illustrating that the risk of multiple pregnancies remains considerable after replacement of more than one thawed embryo. Such risks must be taken into account in establishing transfer policies and in particular if the original goal is to limit the multiple pregnancy rates to a minimum. Overall, we can say at this point that the effectiveness of a transfer strategy is related to both delivery and total cycle number, the latter reflecting patient constraints. The ratio between cycle and delivery numbers was thus higher in the eSET than the SBT group (4.65 versus 3.49 cycles/delivery, respectively; P , 0.04), which reflects the increased number of interventions to reach the same result. This result should therefore be borne in mind during patient counseling. Finally, the efficacy of single embryo transfer at the blastocyst stage should be fully optimized by improving blastocyst cryopreservation procedures.
